Funding for this research was provided by:
general therapeutics (Not applicable)
Received: 25 July 2021
Accepted: 12 August 2021
First Online: 20 August 2021
: The study is registered in ClinicalTrials.gov; Identifier: NCT04971798; URL: ExternalRef removed. Ethics approval for this study was obtained from the South Texas Orthopaedic Research Institute – Institutional Review Board on July 18, 2021 (IRB unique identifier: STORI07182021-1; study number: STORI7182021-1). This study is version 1.0, dated April 28, 2021. Date of recruitment is expected on January 2022 and will be completed on December 31, 2024.The results from this study will be disseminated through manuscript publication in peer-reviewed journal and conference presentations at regional, national, and international platforms.
: Not applicable; no personally identifiable information will be published.
: AG, RJM, CC, EDC, and AGP owns equity in General Therapeutics. The remaining authors declare that they have no competing interests.